Sveriges mest populära poddar

Ep. 3 - Surveying the Landscape for Biopharmas

15 min•28 april 2020

Om avsnittet

BioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.

Reach us by sending a text

Fler avsnitt

BioCentury This Week med BioCentury finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.

Ep. 3 - Surveying the Landscape for Biopharmas

Om avsnittet

Fler avsnitt

Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners

Ep. 390 - Live from Amsterdam: Grand Rounds Europe takeaways

Ep. 389 - IgA nephropathy, Overton hearing, reverse mergers' new look

Ep. 388 - Biotech IPOs, CAR T safety & pharma tariffs

Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs

Ep. 386 - Novartis misses, pharma deals analysis, MFN carve-outs

Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton

Ep. 384 - Back to School Special: The global FIH trials race

Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick

Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA